BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27391789)

  • 21. A Hypoxia-Responsive Albumin-Based Nanosystem for Deep Tumor Penetration and Excellent Therapeutic Efficacy.
    Yang G; Phua SZF; Lim WQ; Zhang R; Feng L; Liu G; Wu H; Bindra AK; Jana D; Liu Z; Zhao Y
    Adv Mater; 2019 Jun; 31(25):e1901513. PubMed ID: 31069885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
    Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of chlorin e6-conjugated poly(ethylene glycol)-poly(d,l-lactide) nanoparticles for photodynamic therapy.
    Kumari P; Rompicharla SVK; Bhatt H; Ghosh B; Biswas S
    Nanomedicine (Lond); 2019 Apr; 14(7):819-834. PubMed ID: 30874479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diselenide linkage containing triblock copolymer nanoparticles based on Bi(methoxyl poly(ethylene glycol))-poly(ε-carprolactone): Selective intracellular drug delivery in cancer cells.
    Hailemeskel BZ; Hsu WH; Addisu KD; Andrgie AT; Chou HY; Lai JY; Tsai HC
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109803. PubMed ID: 31349440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
    Yin N; Yu H; Zhang X; Lv X
    Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyethylene glycol modified ORMOSIL theranostic nanoparticles for triggered doxorubicin release and deep drug delivery into ovarian cancer spheroids.
    Nagesetti A; Srinivasan S; McGoron AJ
    J Photochem Photobiol B; 2017 Sep; 174():209-216. PubMed ID: 28800509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs.
    Figueiredo P; Ferro C; Kemell M; Liu Z; Kiriazis A; Lintinen K; Florindo HF; Yli-Kauhaluoma J; Hirvonen J; Kostiainen MA; Santos HA
    Nanomedicine (Lond); 2017 Nov; 12(21):2581-2596. PubMed ID: 28960138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
    Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticle Delivery of MnO
    Chang CC; Dinh TK; Lee YA; Wang FN; Sung YC; Yu PL; Chiu SC; Shih YC; Wu CY; Huang YD; Wang J; Lu TT; Wan D; Chen Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(40):44407-44419. PubMed ID: 32865389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEG-coumarin nanoaggregates as π-π stacking derived small molecule lipophile containing self-assemblies for anti-tumour drug delivery.
    Behl G; Kumar P; Sikka M; Fitzhenry L; Chhikara A
    J Biomater Sci Polym Ed; 2018 Mar; 29(4):360-375. PubMed ID: 29271302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
    Mondal UK; Doroba K; Shabana AM; Adelberg R; Alam MR; Supuran CT; Ilies MA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer.
    Wan X; Liu C; Lin Y; Fu J; Lu G; Lu Z
    Drug Deliv; 2019 Dec; 26(1):470-480. PubMed ID: 30957572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
    Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
    Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
    Gao W; Xiang B; Meng TT; Liu F; Qi XR
    Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.
    Ray P; Confeld M; Borowicz P; Wang T; Mallik S; Quadir M
    Colloids Surf B Biointerfaces; 2019 Feb; 174():126-135. PubMed ID: 30447521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation.
    Mousa DS; El-Far AH; Saddiq AA; Sudha T; Mousa SA
    Int J Nanomedicine; 2020; 15():2259-2268. PubMed ID: 32280218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug-Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release.
    Li Y; Lin J; Yang X; Li Y; Wu S; Huang Y; Ye S; Xie L; Dai L; Hou Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):17573-81. PubMed ID: 26234408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pterostilbene Nanoparticles Downregulate Hypoxia-Inducible Factors in Hepatoma Cells Under Hypoxic Conditions.
    Tzeng WS; Teng WL; Huang PH; Lin TC; Yen FL; Shiue YL
    Int J Nanomedicine; 2021; 16():867-879. PubMed ID: 33574667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting hypoxic tumor microenvironment in pancreatic cancer.
    Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
    J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.